Ignite Creation Date:
2025-12-24 @ 2:09 PM
Ignite Modification Date:
2025-12-27 @ 9:35 PM
Study NCT ID:
NCT05347095
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-22
First Post:
2022-04-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
Sponsor:
Janssen-Cilag Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-27
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03-25
Completion Date Type:
ESTIMATED
First Submit Date:
2022-04-21
First Submit QC Date:
None
Study First Post Date:
2022-04-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-18
Last Update Post Date:
2025-12-22
Last Update Post Date Type:
ESTIMATED